Background. The World Health Organization (WHO) recently recommended that the time to first malaria episode serve as the primary end point in phase III malaria vaccine trials-the first of which will be held in Africa. Although common red blood cell (RBC) polymorphisms such as sickle hemoglobin (HbS) are known to protect against malaria in Africa, their impact on this end point has not been investigated.
The World Health Organization (WHO) recently recommended that the time to first malaria episode serve as the primary end point in phase III malaria vaccine trials [1] . This end point and the statistical methods used to analyze it, namely time-to-event or survival analysis, are also used in clinical trials of antimalarial drugs [2] and increasingly in observational studies of malaria immunity [3] [4] [5] . Red blood cell (RBC) polymorphisms that produce sickle hemoglobin (HbS), HbC, ␣-thalassemia, glucose-6-phosphate dehydrogenase (G6PD) deficiency, and blood group O are common in the regions of Africa where such studies are conducted. The prevalence of sickle cell trait (HbAS), for example, exceeds 25% in some areas [6] . Although these RBC polymorphisms are associated with decreased risk of malaria, as measured by odds ratios [7] [8] [9] [10] [11] or incidence rate ratios [12] , their impact on the time to first malaria episode is not known. Evidence of a significant effect would provide a rationale for routine typing of RBC polymorphisms in clinical trials and observational studies of malaria that use this end point.
To this end, we investigated the impact of common RBC polymorphisms on the time to first malaria episode in the context of a longitudinal study in which individuals were enrolled during a period of little or no Plasmodium falciparum transmission and then followed up clinically through an 8-month malaria season. In the present article, we describe this observational cohort study designed to investigate the acquisition and maintenance of malaria immunity. We found that HbAS is associated with a 34-day delay in the median time to first malaria episode, an association that remained statistically significant in multivariate Cox regression analysis. HbAS was unique in this regard as we found no association between HbAC, ␣-thalassemia, G6PD deficiency, or blood group O and a delayed time to first malaria episode.
METHODS

Study site.
The study was carried out in Kambila, a small (ϳ1 km 2 ), well-circumscribed, rural village with a population of 1500, situated 20 km north of Bamako, the capital of Mali (figure 1). The transmission of P. falciparum is seasonal and intense, peaking in September through November (figure 2). The entomological inoculation rate measured in a nearby village was near 0 during the dry season, and there were approximately 50 -60 infective bites per person per month in October 2000 [13] .
Sampling strategy, study participants, and malaria case definition. Approval for this study was obtained from the Faculty of Medicine, Pharmacy, and Odonto-Stomatology Ethics Committee; and the institutional review board at the National Institute of Allergy and Infectious Diseases, National Institutes of Health. Written, informed consent was obtained from adult participants, and from the parents or guardians of participating children. The study was externally monitored for protocol compliance, data integrity, and protection of human subjects.
This study is part of an ongoing observational study of the acquisition and maintenance of malaria immunity that began in May 2006 . Individuals were invited to be screened for the study after being randomly selected from an age-stratified census of the entire village population. Enrollment exclusion criteria were hemoglobin level Ͻ7 g/dL, fever 37.5°C, acute systemic illness, use of antimalarial or immunosuppressive medications in the past 30 days, and pregnancy. Venous blood samples and blood smears were collected before the malaria season (May 2006) , at cross-sectional time points every 2 months during the malaria season (July, October, and December 2006), prior to the second malaria season (May 2007) , and 14 days after the first episode of malaria. Stool and urine samples were examined at enrollment for the presence of helminth and Schistosoma haematobium infection, respectively.
Participants were encouraged to report symptoms of malaria at the village health center, which was staffed 24 hours a day by a study physician. For subjects with signs or symptoms of malaria, blood smears were prepared and examined for the presence of P. falciparum. Patients with positive smear results were treated with a standard 3-day course of artesunate plus amodiaquine, following the guidelines of the Mali National Malaria Control Program. Children with severe malaria were referred to Kati District Hospital after an initial parenteral dose of quinine. The research definition of malaria was an axillary temperature 37.5°C, P. falciparum asexual parasitemia 5000 parasites/L, and a nonfocal physical exam by the study physician. Severe malaria, as defined by the WHO [14] , was included in this definition. At the end of the malaria season, participants (or their parents or guardians, in the case of children) were asked whether or not they had used a bed net nightly during the rainy season.
Blood samples. Blood samples were drawn by venipuncture into sodium citrate-containing cell preparation tubes (BD) and transported to the laboratory (20 km) for processing within 2 h. Following centrifugation (1800 relative centrifugal force; 20 min), plasma was collected and stored at Ϫ80°C for future studies. Peripheral blood mononuclear cells were collected, washed twice with sterile phosphate buffered saline (PBS; KD Medical), resuspended in 90% heat-inactivated fetal bovine serum (FBS; Gibco) and 7.5% dimethyl sulfoxide (DMSO; Sigma-Aldrich), kept at Ϫ80°C for 24 h, and transferred to liquid nitrogen for future studies. Two hundred microliters of whole blood was used to identify RBC polymorphisms.
Identification of RBC polymorphisms. Hemoglobin was typed by high-performance liquid chromatography (D-10 instrument; Bio-Rad). The 3.7-kb deletional determinant of ␣-thalassemia was detected by a nested polymerase chain reaction (PCR) protocol (Appendix) to identify heterozygous (Ϫ␣/ ␣␣) and homozygous (Ϫ␣/Ϫ␣) individuals. The mutation responsible for G6PD deficiency in Mali (G6PD*AϪ) was identified by restriction-fragment length polymorphism analysis of PCR-amplified DNA samples, as described elsewhere [10] . ABO blood groups were determined by use of a monoclonal antibody-based kit (Linear Chemicals).
Malaria slides.
Thick blood smears were stained with Giemsa and counted against 300 leukocytes. P. falciparum densities were recorded as the number of asexual parasites per microliter of whole blood, based on a mean leukocyte count of 7500 cells/ L. Each smear was evaluated separately by 2 expert microscopists blinded to the clinical status of study participants. Any discrepancies were resolved by a third expert microscopist.
Stool and urine exam for helminth infection. At enrollment, duplicate stool samples were examined for S. mansoni eggs and other intestinal helminths by use of the semiquantitative Kato-Katz method. To detect S. haematobium eggs, 10 mL of urine were poured over Whatman filter paper. One or two drops of ninhydrin were placed on the filter and left to air dry. After drying, the filter was dampened with tap water, and helminth eggs detected by microscopy.
Geographic information system data collection. Latitude and longitude coordinates and the altitude of study subjects' households were measured by a handheld global positioning system receiver (GeoXM; Trimble).
Data management and analysis. Data were double entered and verified in a database (Microsoft Access 2003; Microsoft) and analyzed using Stata software (version 10.0; StataCorp). Fisher's exact tests and Kruskall-Wallis tests were used to compare binary outcomes and continuous variables between groups, respectively. The probability of a subject remaining malaria-free over an 8-month period was estimated by the Kaplan-Meier method, and the time-to-event curves of different groups were compared by the log rank test. The Cox proportional hazards model was used to assess the effect of the following factors on risk of malaria: age, sex, weight, ethnicity, distance of resi- dence from clinic, bed net use, baseline P. falciparum parasitemia, helminth infection, HbAS phenotype, HbAC phenotype, G6PD*AϪ genotype (hemizygosity, heterozygosity, and homozygosity), Ϫ␣/␣␣ genotype, and ABO blood group. The same list of variables was included in a Poisson regression model to determine their impact on malaria incidence. The covariates included in the final Cox and Poisson regression models were determined by applying the stepwise model selection procedure, in which P values Ͻ.1 and Ͼ.2 were set as criteria for covariate inclusion and removal, respectively. For all tests, 2-tailed P values were considered significant if they were .05.
RESULTS
Baseline characteristics of study cohort.
Of the 237 individuals screened, 225 were enrolled during a 2-week period in May 2006 , approximately 1 month before the malaria transmission season began (figure 2). The study cohort was divided into 4 predefined age groups: 2-4 years (n ϭ 73), 5-7 years (n ϭ 52), 8 -10 years (n ϭ 51), and 18 -25 years (n ϭ 49). Follow-up at scheduled cross-sectional visits was Ͼ99% for children and 82% for adults during the 8-month study. Table 1 shows baseline demographic and clinical characteristics according to age group. Overall, 115 (51.1%) of 225 subjects were female, and the predominant ethnic groups were Bambara (134 [59.6]%) and Sarakole (77 [34.2]%). The prevalence of asymptomatic parasitemia at enrollment was 7.1% (16 subjects) and did not vary significantly with age (P ϭ .83). Of note, asymptomatic parasitemia during the dry season is commonly observed in Mali [15, 16] . Of 190 subjects with stool sample data available, 17 (9.0%) showed evidence of intestinal helminths; of 184 subjects with urine sample data available, 11 (6.0%) showed evidence of S. haematobium infection. These prevalences were lower than expected, likely due to communitywide albendazole treatment prior to this study. The mean distance between the study clinic and subjects' residences was 382 meters (range, 127-881 meters), and 61 (27.1%) of 225 participants self-reported nightly bed net use during the rainy season.
Prevalence of RBC polymorphisms. HbAS and HbAC phenotypes were present in 22 (10.4%) and 29 (13.7%) of 212 individuals, respectively ( Malaria outcomes by age group. A record of the number of malaria cases per day from May 2006 to January 2007 (figure 2) illustrates the intense, seasonal malaria transmission at this site. During 495 clinic visits that occurred during the study period, 298 episodes of malaria were diagnosed. Table 3 summarizes malaria outcomes according to age group. As expected, malaria incidence decreased with age (P Ͻ .001), and the 5 cases of severe malaria were confined to children 5 years old. Among those who presented with malaria, the median time to first malaria episode (as measured in days from study enrollment) increased with age (101 days for subjects 2-4 years old vs. 153 days for subjects 18 -25 years old; P ϭ .016). The geometric mean parasite density per microliter at time of the first malaria episode decreased with age (P ϭ .036).
Impact of RBC polymorphisms on malaria outcomes among children aged 2-10 years. Because adult subjects had few episodes of malaria (table 3) , the analysis of RBC polymorphisms and malaria outcomes focused on children aged 2-10 years. Time-to-event analysis ( figure 3A) showed that HbAS was associated with a significant delay in the time to first malaria episode (P ϭ .038 by log rank test). Among children who presented with malaria, HbAS was associated with a median 34-day delay to the first episode, compared with the non-HbAS group (median, 145 days for the HbAS group vs. 111 days for the nonHbAS group; P ϭ .017). HbAS was also associated with a 53% reduction in malaria incidence ( figure 3B-3D ) or a decreased incidence of malaria (not shown).
Baseline characteristics of children aged 2-10 years, stratified by hemoglobin type. To assess for potential confounding of the protective effect of HbAS, factors that might influence malaria risk were stratified by Hb type (table 4). While there was a higher proportion of females in the HbAS group (P ϭ .022), HbAS children did not differ significantly from non-HbAS chil- NOTE. Data are no. of subjects with a given trait/no. of subjects for whom data was available (%). There were 225 subjects enrolled: 73 in the 2-4 years group, 52 in the 5-7 years group, 51 in the 8 -10 years group, and 49 in the 18-25 group. dren with regard to age, weight, ethnicity, distance of residence from the clinic, or frequency of G6PD*AϪ and Ϫ␣/␣␣ genotypes. The prevalence of asymptomatic parasitemia at enrollment was 9.4% (12 of 128) among HbAA children and 0% (0 of 41) among HbAC and HbAS children. However, asymptomatic parasitemia at enrollment was associated with a delayed time to first malaria episode ( figure 3E ; P ϭ .026, by log rank test) and a trend toward decreased malaria incidence. Thus, HbAS children were not delayed in their time to first malaria episode as a result of the effect of asymptomatic parasitemia. There were too few HbAS children to make meaningful comparisons with respect to the remaining variables. P ϭ .005) were significant predictors of decreased malaria incidence, whereas asymptomatic parasitemia at enrollment was not (P Ͼ .100). Removal of the Ϫ␣/␣␣ genotype from the analysis decreased the hazard ratio (HR, 0.44; P ϭ .020) and incidence rate ratio (IRR, 0.44; P ϭ .004) for HbAS, indicating negative epistasis between these polymorphisms. Factors that did not independently predict either measure of malaria risk (hazard ratio or incidence rate ratio) were sex, weight, distance of residence from clinic, bed net use, helminth infection, HbAC phenotype, G6PD*AϪ genotype (hemizygosity, heterozygosity, or homozygosity), Ϫ␣/␣␣ genotype, and blood group O.
DISCUSSION
In the present study, we found that HbAS was associated with a delayed time to first malaria episode, an association that remained statistically significant in multivariate Cox regression analysis. Numerous case-control studies [7, [17] [18] [19] [20] and longitudinal studies [12, 21] have established that HbAS decreases the risk of malaria, as measured by odds and incidence rate ratios, respectively. However, the effect of HbAS on the time to first malaria episode had not been established using time-to-event analysis. Aidoo et al. showed by time-to-event analysis that HbAS is associated with a reduction in all-cause mortality, but malaria-specific outcomes, including severe malarial anemia and high-density parasitemia, were reported as incidence rates [21] . In Gabon, investigators found no association between HbAS and time to malaria episodes [19] , but the results of this study are difficult to interpret for the following reasons: (1) individuals were initially enrolled in a hospital-based, case-control study of severe malaria; (2) age and other covariates were not taken into account when HbAS and non-HbAS individuals were compared longitudinally; and (3) statistical methods were chosen that were inappropriate for the analysis of correlated sojourn times between consecutive malaria episodes for the same subject. This approach is further complicated by the problem of defining when a malaria episode ends and when an individual becomes susceptible to subsequent episodes after treatment.
Several features of our study made it well-suited to assess the impact of RBC polymorphisms on the time to first malaria episode. The study population was an age-stratified, random sample that represented 15% of all individuals living in a rural, wellcircumscribed, nonmigratory community where antimalarial drugs were provided exclusively by the study investigators. En- rollment occurred over a short period of time, approximately 1 month prior to the abrupt onset of malaria transmission (figure 2). Ninety-three percent of individuals had blood smears negative for P. falciparum at the time of enrollment, obviating the need for a treatment-reinfection study design [22] , an approach that may alter the subsequent risk of malaria [23] . Moreover, the following aspects of our study favored an unbiased detection of malaria episodes: (1) follow-up at regular cross-sectional visits was Ͼ99% among children aged 2-10 years, indicating a high degree of study awareness and participation; (2) the average distance from individuals' homes to the study clinic was 382 meters, minimizing geographic and logistic barriers to study participation; and (3) a study physician was available at all times at the only easily accessible health care facility in the area. The use of time to first malaria episode as a study end point is increasingly common in clinical trials of malaria vaccines [24] and antimalarial drugs [2] and in observational studies of malaria immunity [3] [4] [5] . Indeed, the WHO recently recommended that the time to first malaria episode serve as the primary end point in phase III clinical trials of candidate malaria vaccines [1] . An imbalance in the distribution of HbAS between comparator groups, whether in randomized trials or observational studies, may occur by chance and lead to invalid conclusions. The clear impact of HbAS on this end point and the possibility of a biological interaction between HbAS and certain interventions (e.g., candidate blood stage vaccines) provide a rationale for routine Hb typing in such studies, which are often conducted in areas where the prevalence of HbAS exceeds 25% [6] . To date, Hb typing has not been consistently reported in such studies [5, 24, 25] . Hb typing not only determines whether HbAS was successfully randomized in clinical trials, but incorporating the information into data analyses can increase the statistical power for detecting the effect of an intervention and hence reduce the sample size required. This is particularly important in malaria vaccine trials in which the current vaccine candidates are anticipated to have relatively low efficacy (e.g., 50%) [26] .
Several mechanisms have been proposed to explain how HbAS confers protection against malaria, including decreased RBC invasion or poor growth under low-oxygen tension [27, 28] , enhanced removal of parasitized RBCs [29, 30] , accelerated acquisition of antibodies specific for Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP-1) and other variant surface antigens [31, 32] , and more recently, reduced cytoadherence of parasitized RBCs [33] . Anti-PfEMP-1 antibodies could thus work cooperatively with HbS to further reduce cytoadherence [33] , which may explain the apparent effects of ageassociated acquired immunity on malaria protection by sickle cell trait [34] . It is conceivable that any one of these processes, or a combination of them, underlies the association between HbAS and the delayed time to first malaria episode observed in this study, either by prolonging the time it takes to achieve symptomatic parasite densities or increasing the probability that asymptomatic infections will be aborted. Because we did not actively survey for asymptomatic parasitemia, we could not distinguish between these 2 possibilities. The former idea is supported by the results of a study in Senegal in which weekly blood smears performed after quinine treatment showed a delay in the reappearance of asymptomatic parasitemia in HbAS individuals [22] . However, the relationship between asymptomatic parasitemia and the subsequent risk of malaria is complex and not fully understood [35, 36] .
It is unlikely that differential mosquito exposure confounded the association between HbAS and the time to first malaria episode because HbAS individuals appeared to be randomly distributed in this small, well-circumscribed village, which lacks a dominant body of water ( figure 1) . Moreover, the frequency of bed net use was evenly distributed between HbAS and nonHbAS individuals. It is also unlikely that access to the study clinic played a significant role because the distance to the clinic from the individuals' residences did not differ by hemoglobin type.
G6PD*AϪ and Ϫ␣/␣␣ genotypes, as well as blood group O, have been associated with protection from severe malaria [9 -11] , but their role in protection against uncomplicated malaria is less clear. Consistent with this, we did not observe an association between these polymorphisms and the time to first malaria episode or malaria incidence, although more subtle effects may have been detectable with a larger sample size. Notably, we did not detect an increase in the incidence of uncomplicated malaria among females heterozygous for G6PD*AϪ, which has been observed by others [19, 37, 38] . Consistent with a recent study [20] , we observed negative epistasis between HbAS and the Ϫ␣/␣␣ genotype. However, the frequency of the Ϫ␣/Ϫ␣ genotype in this cohort was too low to confirm the negative epistatic interaction with HbAS reported elsewhere [39] .
Interestingly, asymptomatic parasitemia at enrollment (at the end of the dry season) was associated with a decreased risk of subsequent malaria in multivariate analysis. This finding is consistent with those of a recent longitudinal study in Senegal, where malaria is also highly seasonal [36] . In Uganda, however, where malaria is mesoendemic, asymptomatic parasitemia was reported as a risk factor for malaria [35] , suggesting that the clinical outcome of asymptomatic parasitemia might vary with the epidemiological setting. In neither of these studies, however, were HbAS and other malaria-protective polymorphisms investigated as potential contributing factors. In-depth studies of both host and parasite factors may reveal important mechanisms by which host immune responses and parasite immune evasion are balanced.
The delayed presentation of malaria associated with HbAS in this study adds to the measures by which the protective effect of this remarkable polymorphism has been documented. Clinical studies of malaria that use the time to first malaria episode as an end point should incorporate routine Hb typing in the study design to account for its effect. It appears that other common RBC polymorphisms do not significantly impact this end point, though this may vary in different epidemiological settings. Although this study was designed to investigate the acquisition and maintenance of malaria immunity, the observed effects of HbAS validate this study's ability to detect factors that influence malaria morbidity.
